PMID- 21997384 OWN - NLM STAT- MEDLINE DCOM- 20120327 LR - 20220310 IS - 1420-9071 (Electronic) IS - 1420-682X (Print) IS - 1420-682X (Linking) VI - 69 IP - 5 DP - 2012 Mar TI - Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. PG - 763-81 LID - 10.1007/s00018-011-0846-8 [doi] AB - Contact allergies are complex diseases, and one of the important challenges for public health and immunology. The German 'Federal Institute for Risk Assessment' hosted an 'International Workshop on Contact Dermatitis'. The scope of the workshop was to discuss new discoveries and developments in the field of contact dermatitis. This included the epidemiology and molecular biology of contact allergy, as well as the development of new in vitro methods. Furthermore, it considered regulatory aspects aiming to reduce exposure to contact sensitisers. An estimated 15-20% of the general population suffers from contact allergy. Workplace exposure, age, sex, use of consumer products and genetic predispositions were identified as the most important risk factors. Research highlights included: advances in understanding of immune responses to contact sensitisers, the importance of autoxidation or enzyme-mediated oxidation for the activation of chemicals, the mechanisms through which hapten-protein conjugates are formed and the development of novel in vitro strategies for the identification of skin-sensitising chemicals. Dendritic cell cultures and structure-activity relationships are being developed to identify potential contact allergens. However, the local lymph node assay (LLNA) presently remains the validated method of choice for hazard identification and characterisation. At the workshop the use of the LLNA for regulatory purposes and for quantitative risk assessment was also discussed. CI - (c) The Author(s) 2011. This article is published with open access at Springerlink.com FAU - Peiser, M AU - Peiser M AD - Department of Product Safety, German Federal Institute for Risk Assessment (BfR), Thielallee 88-92, 14195 Berlin, Germany. FAU - Tralau, T AU - Tralau T FAU - Heidler, J AU - Heidler J FAU - Api, A M AU - Api AM FAU - Arts, J H E AU - Arts JH FAU - Basketter, D A AU - Basketter DA FAU - English, J AU - English J FAU - Diepgen, T L AU - Diepgen TL FAU - Fuhlbrigge, R C AU - Fuhlbrigge RC FAU - Gaspari, A A AU - Gaspari AA FAU - Johansen, J D AU - Johansen JD FAU - Karlberg, A T AU - Karlberg AT FAU - Kimber, I AU - Kimber I FAU - Lepoittevin, J P AU - Lepoittevin JP FAU - Liebsch, M AU - Liebsch M FAU - Maibach, H I AU - Maibach HI FAU - Martin, S F AU - Martin SF FAU - Merk, H F AU - Merk HF FAU - Platzek, T AU - Platzek T FAU - Rustemeyer, T AU - Rustemeyer T FAU - Schnuch, A AU - Schnuch A FAU - Vandebriel, R J AU - Vandebriel RJ FAU - White, I R AU - White IR FAU - Luch, A AU - Luch A LA - eng PT - Journal Article PT - Review DEP - 20111014 PL - Switzerland TA - Cell Mol Life Sci JT - Cellular and molecular life sciences : CMLS JID - 9705402 RN - 0 (Allergens) SB - IM MH - Allergens/immunology MH - Congresses as Topic MH - Dermatitis, Allergic Contact/epidemiology/*metabolism/prevention & control MH - Humans MH - Immunity, Innate MH - Keratinocytes/cytology/physiology MH - Local Lymph Node Assay MH - Natural Killer T-Cells/cytology/physiology MH - Risk Factors PMC - PMC3276771 EDAT- 2011/10/15 06:00 MHDA- 2012/03/28 06:00 PMCR- 2011/10/14 CRDT- 2011/10/15 06:00 PHST- 2011/06/14 00:00 [received] PHST- 2011/09/20 00:00 [accepted] PHST- 2011/08/29 00:00 [revised] PHST- 2011/10/15 06:00 [entrez] PHST- 2011/10/15 06:00 [pubmed] PHST- 2012/03/28 06:00 [medline] PHST- 2011/10/14 00:00 [pmc-release] AID - 846 [pii] AID - 10.1007/s00018-011-0846-8 [doi] PST - ppublish SO - Cell Mol Life Sci. 2012 Mar;69(5):763-81. doi: 10.1007/s00018-011-0846-8. Epub 2011 Oct 14.